Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-14

Clinical Trial Update: Efficacy and Safety of TELMINUVO to Stage 2 Hypertension [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports on the efficacy and safety of TELMINUVO for stage 2 hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TELMINUVO

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 3 | Status: UNKNOWN